Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.

Imahashi M, Izumi T, Watanabe D, Imamura J, Matsuoka K, Ode H, Masaoka T, Sato K, Kaneko N, Ichikawa S, Koyanagi Y, Takaori-Kondo A, Utsumi M, Yokomaku Y, Shirasaka T, Sugiura W, Iwatani Y, Naoe T.

PLoS One. 2014 Mar 25;9(3):e92861. doi: 10.1371/journal.pone.0092861. eCollection 2014.

2.

APOBEC3B deletion and risk of HIV-1 acquisition.

An P, Johnson R, Phair J, Kirk GD, Yu XF, Donfield S, Buchbinder S, Goedert JJ, Winkler CA.

J Infect Dis. 2009 Oct 1;200(7):1054-8. doi: 10.1086/605644.

3.

No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations.

Itaya S, Nakajima T, Kaur G, Terunuma H, Ohtani H, Mehra N, Kimura A.

J Infect Dis. 2010 Sep 1;202(5):815-6; author reply 816-7. doi: 10.1086/655227. No abstract available.

4.

Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.

Ezzikouri S, Kitab B, Rebbani K, Marchio A, Wain-Hobson S, Dejean A, Vartanian JP, Pineau P, Benjelloun S.

J Viral Hepat. 2013 Oct;20(10):678-86. doi: 10.1111/jvh.12042. Epub 2012 Dec 28.

PMID:
24010642
5.

Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria.

Jha P, Sinha S, Kanchan K, Qidwai T, Narang A, Singh PK, Pati SS, Mohanty S, Mishra SK, Sharma SK, Awasthi S, Venkatesh V, Jain S, Basu A, Xu S; Indian Genome Variation Consortium, Mukerji M, Habib S.

Infect Genet Evol. 2012 Jan;12(1):142-8. doi: 10.1016/j.meegid.2011.11.001. Epub 2011 Nov 12.

PMID:
22108670
6.

D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

McDougle RM, Hultquist JF, Stabell AC, Sawyer SL, Harris RS.

Virology. 2013 Jun 20;441(1):31-9. doi: 10.1016/j.virol.2013.03.003. Epub 2013 Mar 29.

7.

Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Veloso S, Olona M, García F, Domingo P, Alonso-Villaverde C, Broch M, Peraire J, Viladés C, Plana M, Pedrol E, López-Dupla M, Aguilar C, Gutiérrez M, Leon A, Tasias M, Gatell JM, Richart C, Vidal F.

BMC Med Genet. 2010 Apr 26;11:63. doi: 10.1186/1471-2350-11-63.

8.

Characterization of the relationship between APOBEC3B deletion and ACE Alu insertion.

Wang K, Li Y, Dai C, Wang K, Yu J, Tan Y, Zhang W, Yu XF.

PLoS One. 2013 May 24;8(5):e64809. doi: 10.1371/journal.pone.0064809. Print 2013.

9.

Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.

Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, Zhai K, Bi X, Zhao H, Xu J, Tan W, Qu C, Lin D.

Hum Mol Genet. 2013 Mar 15;22(6):1262-9. doi: 10.1093/hmg/dds513. Epub 2012 Dec 4.

10.

The VNTR polymorphism of the CLEC4M gene and susceptibility to HIV-1 infection in Han Chinese population.

Li H, Fu WP, Hong ZH.

Infect Genet Evol. 2013 Jul;17:137-41. doi: 10.1016/j.meegid.2013.04.007. Epub 2013 Apr 17.

PMID:
23602836
11.

A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.

Xu L, Qiao Y, Zhang X, Sun H, Wang J, Sun D, Jia X, Shen C, Zhao Y, Jin Y, Yu Y, Ling H, Wang K, Fu S.

Mol Biol Rep. 2011 Jan;38(1):327-32. doi: 10.1007/s11033-010-0111-5. Epub 2010 Apr 4.

PMID:
20364409
12.

Interferon regulatory factor 1 polymorphisms previously associated with reduced HIV susceptibility have no effect on HIV disease progression.

Sivro A, McKinnon LR, Ji H, Kimani J, Jaoko W, Plummer FA, Su RC, Ball TB.

PLoS One. 2013 Jun 14;8(6):e66253. doi: 10.1371/journal.pone.0066253. Print 2013.

13.

The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.

van Manen D, Rits MA, Beugeling C, van Dort K, Schuitemaker H, Kootstra NA.

PLoS Pathog. 2008 Feb 8;4(2):e18. doi: 10.1371/journal.ppat.0040018.

14.

The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.

Paxton WA, Kang S, Koup RA.

AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S89-92.

PMID:
9581891
15.

Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children.

Fabris A, Catamo E, Segat L, Morgutti M, Arraes LC, de Lima-Filho JL, Crovella S.

AIDS. 2009 Jan 14;23(2):177-82. doi: 10.1097/QAD.0b013e32832027bf.

PMID:
19098486
16.

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

Doehle BP, Schäfer A, Cullen BR.

Virology. 2005 Sep 1;339(2):281-8.

17.

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Pine SO, McElrath MJ, Bochud PY.

AIDS. 2009 Nov 27;23(18):2387-95. doi: 10.1097/QAD.0b013e328330b489.

18.
19.

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81.

PMID:
11511825
20.

TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.

Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, Luban J, Kasprowicz V, Dheda K, Abdool Karim SS, Ndung'u T.

J Virol. 2014 Apr;88(8):4291-303. doi: 10.1128/JVI.03603-13. Epub 2014 Jan 29.

Items per page

Supplemental Content

Write to the Help Desk